Browse resources

Region: Global

Total results with these characteristics: 934

Page 5 of 38  
‹ prev.
2
3
4
5
6
7
8
next ›

The Complex Journey of a Vaccine

This infographic provides a visual description of the complicated route that vaccines follow for manufacturing, formulation, packaging, and distribution, including where quality control testing is completed at each step in the process.

Author: International Federation of Pharmaceutical Manufacturers & Associations

Published: 2014

A Comprehensive Approach to Rotavirus Vaccines

This fact sheet highlights PATH's work to address rotavirus and includes general information about its efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines.

Author: PATH

Published: 2011

Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women

This World Health Organization Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control and is aimed at senior policy makers and programme managers. It describes the need to deliver effective interventions …

Author: World Health Organization

Published: 2013

Computerizing Logistics Management Information Systems: A Program Manager’s Guide

As in-country public health logistics systems become more integrated and sophisticated, many countries are looking to automate their logistics management information systems (LMIS) in order to improve the quantity, quality, and timeliness of …

Author: US Agency for International Development's DELIVER PROJECT

Published: 2012

Conducting Formative Research for HPV Vaccination Program Planning: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Published: 2012

Conjugate Vaccines

This review, published in Expert Review of Vaccines, looks at what has been learned from developing conjugate vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and group C Neisseria meningitidis that could be useful for the …

Author: Lockhart S

Published: 2003

Conjugate Vaccines and the Carriage of Haemophilus influenzae type b

Many junior doctors today have not had occasion to treat a child for Hib disease. The remarkable absence of cases of this disease is due to the use of conjugate vaccines. In countries with established Hib vaccination programs the incidence of …

Author: Barbour M

Published: 1996

The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II

To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent pneumococcal disease studies and assessed the relative frequency of isolation of each …

Author: Hausdorff WP, Bryant J, Paradiso P, Siber G

Published: 2000

Control of Epidemic Meningococcal Disease. WHO Practical Guidelines. 2nd Edition

These guidelines, designed for physicians, laboratory workers, and health care administrators, provide comprehensive information on epidemiology and standard techniques for diagnosis, treatment, prevention, and control of meningococcal disease …

Author: World Health Organization

Published: 1998

Control of Japanese Encephalitis--Within Our Grasp?

The article, from the New England Journal of Medicine, provides an up-to-date summary of JE disease incidence, epidemiology, and vaccines against JE.

Author: Solomon T

Published: 2006

Coordinated Surveillance and Detection of Pneumococcal and Haemophilus influenzae type b (Hib) Disease in Developing Countries

This supplemental issue of Clinical Infectious Diseases provides numerous articles on the surveillance and detection of pneumococcal and Haemophilus influenzae type b disease in developing countries. Topics include progress and challenges in disease …

Author: Black S, Knoll MD, eds.

Published: 2009

The Cornerstone of Public Health

This fact sheet makes the case for why vaccines are a critical, cost-effective investment for improving global health and saving children's lives.

Author: PATH

Published: 2013

Correlates of Protection: Novel Generations of Influenza Vaccines

This article, published in the journal Vaccine, reviews potential correlates of protection against influenza and discusses some of the vaccination strategies that could result in optimal protection against epidemic and pandemic influenza. ABSTRACT …

Author: Rimmelzwaan GF, McElhaney JE

Published: 2008

The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. The authors of this article, published in Pharmacoeconomics, systematically reviewed the literature on the costs …

Author: Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC

Published: 2013

Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006

This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …

Author: World Health Organization

Published: 2006

The Cost of Immunization Programs in the Next 10 Years

This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.

Author: World Health Organization

Published: 2006

The Cost of Unsafe Injections

Unsafe injection practices are associated with substantial morbidity and mortality. Annually more than 1.3 million deaths and US$535 million in expenses are estimated to be due to unsafe injection practices. This article, published in the Bulletin …

Author: Miller MA, Pisani E

Published: 1999

Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review

This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …

Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS

Published: 2012

Cotton Rats Previously Immunized With a Chimeric RSV FG Glycoprotein Develop Enhanced Pulmonary Pathology When Infected With RSV, a Phenomenon not Encountered Following Immunization With Vaccinia-RSV Recombinants or RSV

In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection …

Author: Connors M, Collins PL, Firestone CY, et al.

Published: 1992

Coverage, Cost, and Safety Impacts of Primary Container Choice

A single decision on the size and type of a vaccine container can have significant implications on the safety, affordability, and coverage of vaccination in routine and campaign settings. Choosing a single-dose vial instead of a multi-dose container …

Author: International Vaccine Access Center

Published: 2013

Current Concepts in Host-Microbe Interaction Leading to Pneumococcal Pneumonia

This article, published in Current Opinion in Infectious Diseases, reviews new insights into the pathogenesis of pneumococcal disease. The authors discuss new mechanisms by which microbial factors govern the ability of pneumococcus to progress from …

Author: Vernatter J, Pirofski L

Published: 2013

Current HPV Vaccines and Future AIDS Vaccines: Common Challenges and Unprecedented Opportunities

This issue brief discusses how ensuring swift and efficient HPV vaccine introduction in developing countries will not only help address the burden of cervical cancer, but will also provide a valuable opportunity for AIDS vaccine researchers and …

Author: AIDS Vaccine Advocacy Coalition, International AIDS Vaccine Initiative, PATH

Published: 2008

Current Knowledge Regarding the Investigational 13-valent Pneumococcal Conjugate Vaccine

This article, published in Expert Reviews of Vaccines, explains the latest knowledge about the investigational 13-valent pneumococcal conjugate vaccine (PCV-13). It outlines the composition of the vaccine and the trials it has undergone to date …

Author: Dinleyici EC, Yargic ZA

Published: 2009

Current Use and Development of Vaccines for Japanese Encephalitis

This literature review, published in Expert Opinion on Biological Therapy, analyzes use of current JE vaccines and development of alternative vaccine candidates. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to …

Author: Beasley D, Lewthwaite P, Solomon T.

Published: 2008

Decade of Vaccines

This supplement to Vaccine features articles on the Decade of Vaccines Global Vaccine Action Plan strategic objectives and the opportunities and challenges associated with its implementation. The 27 articles in the supplement cover a range of …

Author: Alonso PL, de Quadros CA, Lal AA, eds.

Published: 2013

Page 5 of 38  
‹ prev.
2
3
4
5
6
7
8
next ›